n-methyl-3,4-methylenedioxyamphetamine has been researched along with Central Diabetes Insipidus in 1 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Excerpt | Relevance | Reference |
---|---|---|
"Disruptions of the hypothalamic-pituitary axis can cause an arginine vasopressin deficiency, also known as central diabetes insipidus." | 9.69 | Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial. ( Atila, C; Christ-Crain, M; Eckert, A; Heinrichs, M; Holze, F; Hutter, N; Liechti, ME; Murugesu, R; Rommers, N; Sailer, CO; Varghese, N, 2023) |
"Disruptions of the hypothalamic-pituitary axis can cause an arginine vasopressin deficiency, also known as central diabetes insipidus." | 5.69 | Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial. ( Atila, C; Christ-Crain, M; Eckert, A; Heinrichs, M; Holze, F; Hutter, N; Liechti, ME; Murugesu, R; Rommers, N; Sailer, CO; Varghese, N, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Atila, C | 1 |
Holze, F | 1 |
Murugesu, R | 1 |
Rommers, N | 1 |
Hutter, N | 1 |
Varghese, N | 1 |
Sailer, CO | 1 |
Eckert, A | 1 |
Heinrichs, M | 1 |
Liechti, ME | 1 |
Christ-Crain, M | 1 |
1 trial available for n-methyl-3,4-methylenedioxyamphetamine and Central Diabetes Insipidus
Article | Year |
---|---|
Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial.
Topics: Arginine; Case-Control Studies; Cross-Over Studies; Diabetes Insipidus, Neurogenic; Diabetes Mellitu | 2023 |